Start Date
November 26, 2019
Primary Completion Date
November 26, 2019
Study Completion Date
January 26, 2021
Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
480mg IV every 4 weeks
Stereotactic Body Radiation Therapy (SBRT)
SBRT dose of 8-10 Gy x 3 fractions (at maximum 3 doses per week) delivered to 1 extracranial site between days 1-14 of Cycle 1.
Johns Hopkins Bayview, Baltimore
The Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University, Baltimore
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER